276 related articles for article (PubMed ID: 15318937)
1. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
[TBL] [Abstract][Full Text] [Related]
2. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
3. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
Brunsvig PF; Flatmark K; Aamdal S; Høifødt H; Le H; Jakobsen E; Sandstad B; Fodstad O
Lung Cancer; 2008 Aug; 61(2):170-6. PubMed ID: 18261824
[TBL] [Abstract][Full Text] [Related]
5. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K
Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327
[TBL] [Abstract][Full Text] [Related]
7. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.
Naume B; Borgen E; Nesland JM; Beiske K; Gilen E; Renolen A; Ravnås G; Qvist H; Kåresen R; Kvalheim G
Int J Cancer; 1998 Nov; 78(5):556-60. PubMed ID: 9808522
[TBL] [Abstract][Full Text] [Related]
11. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
[TBL] [Abstract][Full Text] [Related]
13. [Comparative characteristic of the methods of immunocytochemistry and immunomagnetic separation for detection of cytokeratin-positive cells in bone marrow and lymph nodes].
Lebedinskaia OV; Shubina IZh; Donenko F; Pirogov AV; Kiselevskiĭ MV
Morfologiia; 2007; 132(4):81-6. PubMed ID: 17969436
[TBL] [Abstract][Full Text] [Related]
14. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
Weihrauch MR; Skibowski E; Koslowsky TC; Voiss W; Re D; Kuhn-Regnier F; Bannwarth C; Siedek M; Diehl V; Bohlen H
J Clin Oncol; 2002 Nov; 20(21):4338-43. PubMed ID: 12409333
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
[TBL] [Abstract][Full Text] [Related]
16. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
[TBL] [Abstract][Full Text] [Related]
17. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
[TBL] [Abstract][Full Text] [Related]
18. Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
Becker S; Becker-Pergola G; Fehm T; Wallwiener D; Solomayer EF
Anticancer Res; 2005; 25(3B):2171-5. PubMed ID: 16158960
[TBL] [Abstract][Full Text] [Related]
19. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
Eide N; Faye RS; Høifødt HK; Sandstad B; Qvale G; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
Acta Ophthalmol; 2015 Feb; 93(1):59-66. PubMed ID: 25613126
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
